secwatch.observer — SEC 8-K summary
======================================

Issuer:     Applied Therapeutics, Inc. (—)
CIK:        0001697532
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001104659-23-072300
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Applied Therapeutics appoints Catherine Thorpe as interim CFO and CAO; Steven Ortega resigns
--------------------------------------------------------------------------------

- Steven Ortega resigns as Chief Accounting Officer and Interim Principal Financial Officer effective June 30, 2023, to pursue another opportunity.
- Catherine Thorpe appointed interim Principal Financial Officer and Chief Accounting Officer effective June 16, 2023.
- Thorpe is a CFGI employee; Company entered an engagement letter with CFGI for financial, accounting, and tax services.
- Company to pay CFGI hourly rate for Thorpe's services; fees expected similar to Ortega's compensation.
- No familial relationships with executives; Thorpe to enter standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697532/000110465923072300/0001104659-23-072300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697532/000110465923072300/tm2318933d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer